Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Animal models to explore the effects of glucocorticoids on skeletal growth and structure

CL. Wood, O. Soucek, SC. Wong, F. Zaman, C. Farquharson, L. Savendahl, SF. Ahmed,

. 2018 ; 236 (1) : R69-R91. [pub] 20171019

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010296

Glucocorticoids (GCs) are effective for the treatment of many chronic conditions, but their use is associated with frequent and wide-ranging adverse effects including osteoporosis and growth retardation. The mechanisms that underlie the undesirable effects of GCs on skeletal development are unclear, and there is no proven effective treatment to combat them. Anin vivomodel that investigates the development and progression of GC-induced changes in bone is, therefore, important and a well-characterized pre-clinical model is vital for the evaluation of new interventions. Currently, there is no established animal model to investigate GC effects on skeletal development and there are pros and cons to consider with the different protocols used to induce osteoporosis and growth retardation. This review will summarize the literature and highlight the models and techniques employed in experimental studies to date.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010296
003      
CZ-PrNML
005      
20180418125800.0
007      
ta
008      
180404s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1530/JOE-17-0361 $2 doi
035    __
$a (PubMed)29051192
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Wood, Claire L $u Division of Developmental BiologyRoslin Institute, University of Edinburgh, Edinburgh, UK.
245    10
$a Animal models to explore the effects of glucocorticoids on skeletal growth and structure / $c CL. Wood, O. Soucek, SC. Wong, F. Zaman, C. Farquharson, L. Savendahl, SF. Ahmed,
520    9_
$a Glucocorticoids (GCs) are effective for the treatment of many chronic conditions, but their use is associated with frequent and wide-ranging adverse effects including osteoporosis and growth retardation. The mechanisms that underlie the undesirable effects of GCs on skeletal development are unclear, and there is no proven effective treatment to combat them. Anin vivomodel that investigates the development and progression of GC-induced changes in bone is, therefore, important and a well-characterized pre-clinical model is vital for the evaluation of new interventions. Currently, there is no established animal model to investigate GC effects on skeletal development and there are pros and cons to consider with the different protocols used to induce osteoporosis and growth retardation. This review will summarize the literature and highlight the models and techniques employed in experimental studies to date.
650    _2
$a zvířata $7 D000818
650    _2
$a geneticky modifikovaná zvířata $7 D030801
650    _2
$a vývoj kostí $x účinky léků $7 D001846
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a glukokortikoidy $x škodlivé účinky $7 D005938
650    _2
$a poruchy růstu $x chemicky indukované $7 D006130
650    _2
$a lidé $7 D006801
650    _2
$a osteoklasty $x účinky léků $7 D010010
650    _2
$a osteocyty $x účinky léků $7 D010011
650    _2
$a osteoporóza $x chemicky indukované $7 D010024
650    _2
$a kostra $x růst a vývoj $7 D012863
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Soucek, Ondrej $u Department of Paediatrics2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. Department of Women's and Children's HealthKarolinska Institutet and Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Wong, Sze C $u Developmental Endocrinology Research GroupSchool of Medicine, University of Glasgow, Glasgow, UK.
700    1_
$a Zaman, Farasat $u Department of Women's and Children's HealthKarolinska Institutet and Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Farquharson, Colin $u Division of Developmental BiologyRoslin Institute, University of Edinburgh, Edinburgh, UK.
700    1_
$a Savendahl, Lars $u Department of Women's and Children's HealthKarolinska Institutet and Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Ahmed, S Faisal $u Developmental Endocrinology Research GroupSchool of Medicine, University of Glasgow, Glasgow, UK Faisal.ahmed@glasgow.ac.uk.
773    0_
$w MED00002653 $t The Journal of endocrinology $x 1479-6805 $g Roč. 236, č. 1 (2018), s. R69-R91
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29051192 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180418125900 $b ABA008
999    __
$a ok $b bmc $g 1287781 $s 1007108
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 236 $c 1 $d R69-R91 $e 20171019 $i 1479-6805 $m Journal of Endocrinology $n J Endocrinol $x MED00002653
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace